NXN-462

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameNXN-462
Drug Alias NameNXN-462
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric-oxide synthase, brain inhibitors
TargetsNitric-oxide synthase, brain
Therapy Area/IndicationsNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeuraxon Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuraxon Inc
Active IndicationsN/A
Inactive IndicationsNeuralgia, Postherpetic

Other Information

ATC CodeN/A
Related LinksN/A